Residential Project with Crystal Lagoons
Sector: Residential • Location: Israel
Source: WJHL
ECIPSA Group and ISRAELCANADA are investing USD 16 million in land in Israel to develop the country's first residential project featuring Crystal Lagoons technology.
- Status
- Prospective
- Sector
- Residential
- Location
- Israel
- Updated
- 22 Jul 2026
- Source
- WJHL
ConstructChat
Ask ConstructChat about Residential Project with Crystal Lagoons
Pick a question to edit it, or write your own.
First answer free · no account
Project Information FAQ
Project Information
Participants
| Not available for this record. |
Status
Original status | Planned |
Taiyo status | Prospective |
Taiyo last update | 2026-07-22 |
Contact
| Not available for this record. |
Description
Description | ECIPSA Group and ISRAELCANADA are investing USD 16 million in land in Israel to develop the country's first residential project featuring Crystal Lagoons technology. |
Budget |
Location
Country | Israel |
Source
Source | WJHL |
URL |
More Details
Record type | Project |
Sector | Residential |
Article published date | 2025-03-07 |
Research
Free account
View all details
You are reading the public part. A free account opens the rest:
- Every detail on this project
- News and media coverage
- Technical research
Free account · no card · lands you back on this project
More Residential projects in Israel
- Cost-effective rehabilitation of public buildings into smart and resilient nano-grids using storage
- D House / Lavan Architects
- Common Ground Collective Garden / el.em studio
- An innovative, effective and minimally-invasive retinal cell therapy combined with a new injection system for treatment of retinal degenerative diseases.
- Decentralized Travel Apartment Distribution Platform
- Dynamic Bright Code: Delivering digital content in offline environments by connecting unique LEDbased optical tags with mobile devices.
- Safe home-based portable peritoneal dialysis system that offers simpler dialysis and improved quality of life for patients
- Innovative, minimally invasive Medical Prostatic Retraction Device for the treatment of Benign Prostatic Hyperplasia (BPH) Patients in the office settings.